- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03913884
Effect of CGF on Short Term Clinical Outcomes After Partially Impacted Mandibular Third Molar Surgery (CGF)
Effect of Concentrated Growth Factor (CGF) on Short Term Clinical Outcomes After Partially Impacted Mandibular Third Molar Surgery: A Split-Mouth Randomized Clinical Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study population was composed of subjects presenting to the Department of Oral Surgery for evaluation and management of bilateral, partially-impacted mandibular third molars. The protocol for this study was approved by the local ethics committee and all participants signed an informed consent.
A patient who was referred for extraction of mandibular third molars was examined clinically and radiologically according to the inclusion criteria.
Before the partially-impacted mandibular third molar surgery, randomisation was achieved by use of sealed envelopes, selected by the patient. The envelopes contained cards labelled 'right' or 'left', which indicated the surgical side to receive CGF application.The envelopes were opened by the surgeon after the patients made their selection.
Both partially-impacted mandibular third molars were extracted by the same experienced surgeon. For each patient, the sites operated on were randomly divided into two study groups.
Group I (test); in which CGF fibrin matrix was applied to the extraction socket Group II (control); in which CGF was not applied to the extraction socket Each patient was listed for two surgical appointments. The second extraction was done on the control side, three weeks after the first extraction.
Patients were blind as to which side the CGF was placed, in order to avoid any influence on visual analog scale (VAS) scores. To obtain an objective assessment of pain, patients were informed that CGF application was used on all sites by the surgeon. The surgeon was not blind to the CGF application or the suturing. Therefore, clinical parameters were assessed based on the classifications by an independent observer specializing in oral surgery.
Study variables The primary variable of this clinical study was CGF application. CGF Preparation CGF was prepared according to Sacco protocol. The patients' blood was collected in 9 ml glass two tubes with vacutainer. The tubes were centrifuged immediately in a special centrifuge device (Medifuge, France). After the following settings were used: 2 min 2700 rpm, 4 min 2400 rpm, 4 min 2700 rpm and 3 min 3000 rpm, three layers were observed in the tubes. The upper layer, comprising platelet-poor plasma and the lower one, the red blood cells, were separated from the 'buffy coat', the CGF, by forceps and scissors.
The primary outcome variable was soft tissue healing around the extraction socket. The secondary outcome variables were pain, swelling and trismus.
Before surgery, patients rinsed their mouths with 0.12% clorhexidine gluconate as an antiseptic mouthwash for 60 seconds.
All surgeries were carried out using the same protocol by the same experienced surgeon. As local anesthetic, 2% lidocaine with 1:80.000 epinephrine (1/200.000 Jetokain®, Adeka, İstanbul, Turkey) was applied. A mucoperiosteal flap was elevated to expand initial access without releasing. The surgical approach for each tooth was as follows: bone removal, simple mobilization, extraction of tooth without sectioning and curettage of the socket. After extraction, the socket was irrigated using 60 mL of sterile saline.
CGF fibrin matrix was placed in one socket which was randomly selected (test side). After three weeks, extraction of the tooth on the opposite site was performed and the socket left to heal naturally (control side). The flap was sutured with 4/0 atraumatic silk suture (½ cutting edge, 75 cm, Doğsan, İstanbul, Turkey) for each surgical site.
Postoperatively, amoxicillin (500 mg/8 h, Largopen®, Bilim Pharmaceuticals, İstanbul, Turkey for five days), 0.2% chlorhexidine mouthwash (twice per day for seven days; Kloroben®, Drogsan Pharmaceuticals, Ankara, Turkey) and paracetamol (500 mg, every 4-6 h, Parol®, Atabay Pharmaceuticals, İstanbul, Turkey) were prescribed by the surgeon. After one week, sutures were removed.
All subjects were recalled postoperatively at the 3rd and 7th days by the blinded examiner. Soft tissue healing, pain, swelling and trismus were evaluated on the 3rd and 7th days and pain scores, noted from 1st to 7th days by the patient, were collected. Demographic values for patients' age and gender were also noted.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Bornova
-
İzmir, Bornova, Turkey, 35040
- Ege University, Faculty of Dentistry
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
1- Bilateral, vertically, partially-impacted Class I, Level B third molars
Exclusion Criteria:
- Infection of the surgical region
- Smoking habit
- Alcohol usage
- Physical or mental disability
- Thrombocytopenia
- Chemotherapy in head and neck region
- Pregnant woman or woman in menstrual cycle
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Sequential Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Concentrated growth factor Group
Group I (test); in which CGF fibrin matrix was applied to the extraction socket
|
CGF fibrin matrix was placed in one socket which was randomly selected (test side).
The flap was sutured with 4/0 atraumatic silk suture (½ cutting edge, 75 cm, Doğsan, İstanbul, Turkey) for each surgical site.
|
Experimental: Non-Concentrated growth factor Group
Group II (control); in which CGF was not applied to the extraction socket
|
To control group, extraction of the tooth on the opposite site was performed and the socket left to heal naturally.
The flap was sutured with 4/0 atraumatic silk suture (½ cutting edge, 75 cm, Doğsan, İstanbul, Turkey) for each surgical site.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
soft tissue healing
Time Frame: Change of soft tissue healing at 7 days
|
This was assessed on the third and seventh preoperative days using the healing index classified by Landry et al.12.
It depends on tissue colour, presence of bleeding on palpation, epithelization of wound margins, granulation tissue and suppuration, and rates the degree of healing attained from 'very poor' to 'excellent'.
|
Change of soft tissue healing at 7 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
severity of postoperative pain
Time Frame: Change of postoperative pain at 7 days
|
The patients were instructed to note their level of postoperative discomfort and/or pain on the scale, which ranged from 0, indicating no pain, to 100 indicating the worst ever experienced.
Paracetamol (500-mg tablets) was prescribed to be taken postoperatively as needed.
The patients were asked to fill in the questionnaire as required on a daily basis for 7 days.
|
Change of postoperative pain at 7 days
|
presence of swelling
Time Frame: Change of swelling at 7 days
|
three facial measurements were taken with milimetric elastic ruler, preoperatively, as described by Kumar et al., on the third and seventh days after extraction.
These dimensions were as follows: the from the tragus to the pogonion (TP); from the tragus to the corner of the mouth (TC); and from the lateral corner of the eye to the angle of the mandible (EA).
|
Change of swelling at 7 days
|
presence of trismus
Time Frame: Change of trismus at 7 days
|
Inter-incisal distance was measured, as a guide point, with a millimeter ruler.
|
Change of trismus at 7 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Gözde Işık, Oral Surgery
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Faculty of Dentistry
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Edema
-
Eye-yon MedicalCompletedCORNEAL EDEMAIsrael, Poland
-
Federico II UniversityCompletedPseudophakic Cystoid Macular Edema
-
California Retina ConsultantsRegeneron PharmaceuticalsCompletedDiabetic Macular Edema | Cystoid Macular EdemaUnited States
-
Postgraduate Institute of Medical Education and...CompletedDiabetic Macular Edema | Vision Disorders | Macular Edema, Cystoid | Clinically Significant Macular EdemaIndia
-
National Cardiovascular Center Harapan Kita Hospital...CompletedMyocardial Edema
-
OcugenNot yet recruitingDiabetic Macular Edema | Center Involved Diabetic Macular Edema
-
Eye-yon MedicalCompletedChronic Cornel EdemaNetherlands, Israel, Germany, Spain
-
University of RochesterNeuroMetrix, Inc.Active, not recruiting
-
Luca MarinEnrolling by invitation
Clinical Trials on Concentrated growth factor
-
Ege UniversityCompletedInfection | Healing Surgical Wounds
-
West China HospitalRecruitingBone Substitute | Concentrated Growth FactorChina
-
Ege UniversityCompletedAlveolar Osteitis | Impacted ToothTurkey
-
Gazi UniversityAnkara UniversityCompletedPapilla, Dentinal; CalcificationTurkey
-
Dow University of Health SciencesRecruitingTo Assess the Bone Healing in Fracture Mandible DefectsPakistan
-
Uğur Can ÜNLÜGENÇMustafa Kemal UniversityCompletedBone Loss, Alveolar | Osseointegration Failure of Dental Implant | Resorption, BoneTurkey
-
Tanta UniversityCompletedAggressive PeriodontitisEgypt
-
Muhammet AtilganMustafa Kemal UniversityCompletedBone Loss, Alveolar | Edentulous Jaw | Resorption, BoneTurkey
-
Ahmad ElheenyNot yet recruiting
-
Nourhan M.AlyAlexandria UniversityCompletedTemporomandibular Joint Disorders | Temporomandibular DisorderEgypt